Deal Details

• Leading Bulk Drugs manufacturing company, trailing with an experience of more than 2 decades.
• Has diversified portfolio of 10 products across therapeutic categories.
• Specializes in complex chemistry APIs for fast growing therapeutic segments.
• Manufactures API for 10+ molecules across multiple therapeutic areas
• Fully backward integrated API manufacturing capabilities providing cost competitiveness
• Dedicated R&D Infrastructure With Strong Capabilities

Operational Highlights:

• Operates manufacturing blocks with total reactor capacity of
  850 KL, spread over a land of around 30,000 Sq. Mts.
  – Plant units are operated and maintained as per the current GMP standards.
  – Multi Product Facility. Ground+2 Stories Facilities.
  – High temperature reaction
  – Capacity utilization of plant stands at 60% and can enhanced up to 95 % in the current year
• INR 52.21 Crores capex spent in last 5 years
• Two dedicated units towards API and two for Intermediaries
• Installed reaction capacity of 771 KL with 82 stainless steel reactors systems, 27 glass lined reactors and others are 18 systems; facility is equipped with cryogenic reactor